32 results
DEFR14A
RYTM
Rhythm Pharmaceuticals, Inc.
7 Aug 24
Revised proxy
6:00am
EXECUTIVE COMPENSATION
AUDIT COMMITTEE REPORT
PROPOSAL NO. 2—RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
PROPOSAL NO. 3 … to “Executive Compensation” and “Director Compensation” below.
Our Compensation & Management Development Committee is also responsible for overseeing
424B5
n89s7vljpr4er1tzixgs
5 Feb 21
Prospectus supplement for primary offering
5:26pm
424B5
fzgs4f640d85gi5blq
3 Feb 21
Prospectus supplement for primary offering
5:12pm
424B5
j0gozln0zbj gu2vr
16 Oct 19
Prospectus supplement for primary offering
5:25pm
424B5
4wiohd ab
15 Oct 19
Prospectus supplement for primary offering
4:51pm